ScanBalt at BIO 2003
ScanBalt at Bio 2003 – The World’s Largest Gathering of Biotechnology Leaders
The session “ScanBalt: Opportunities in the Baltic Sea Area Through Borderless Biotech” will highlight the ScanBalt progress during its first year and address areas for future focus, such as new industry growth and progress, funding, partnership opportunities and intellectual property protection. Quality infrastructure, resources and intellectual capital already exist in the area, including approximately 60 universities and 870 biotechnology-related companies. The goal is to leverage these resources and assets to foster the industry’s continued
growth and commercialization in this geographic area.
Leslie Platt , J.D., Principal, Ernst & Young LLP
Bo Samuelsson, M.D., Ph.D., Chairman of ScanBalt, Rector, University of Göteborg
Anna Podhajska , M.D., Ph.D., Professor, University of Gdansk
Joergen Dirach, M.D., Research Counselor, Novo Nordisk A/S
Kai Lahtonen, Vice President, Marketing & Business Development, Hormos Medical Corp.
Dr. Wolfgang Blank, Managing Director, BioCon Valley GmbH
Kalev Kask, Ph.D., CEO, EGeen International Corp.
Read more at: www.bio.org/events/2003/
and : http://www.bio.org/events/2003/speaker/session1.asp?
15 June 2022
Startup Call Invites New Businesses to Turku